My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease.

    Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS.

    Alzheimers Res Ther. 2009 Oct 21;1(2):7.PMID: 19845950 [PubMed]Related articlesFree article

    2.

    Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.

    Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swabb EA, Laughlin MA; Tarenflurbil Phase II Study investigators.

    Lancet Neurol. 2008 Jun;7(6):483-93. Epub 2008 Apr 29. Erratum in: Lancet Neurol. 2008 Jul;7(7):575. PMID: 18450517 [PubMed - indexed for MEDLINE]Related articles

    3.

    Donepezil for vascular cognitive impairment.

    Malouf R, Birks J.

    Cochrane Database Syst Rev. 2004;(1):CD004395. Review.PMID: 14974068 [PubMed - indexed for MEDLINE]Related articles

    4.

    Galantamine for Alzheimer's disease.

    Olin J, Schneider L.

    Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747. PMID: 11687119 [PubMed - indexed for MEDLINE]Related articles

    5.

    Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).

    Hanon O, Latour F, Seux ML, Lenoir H, Forette F, Rigaud AS; REAL.FR Group.

    J Nutr Health Aging. 2005;9(2):106-11.PMID: 15791354 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.

    Cortes F, Nourhashémi F, Guérin O, Cantet C, Gillette-Guyonnet S, Andrieu S, Ousset PJ, Vellas B; REAL-FR Group.

    Alzheimers Dement. 2008 Jan;4(1):22-9.PMID: 18631947 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

    Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study.

    JAMA. 2003 Jun 4;289(21):2819-26.PMID: 12783912 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Galantamine for Alzheimer's disease.

    Olin J, Schneider L.

    Cochrane Database Syst Rev. 2002;(3):CD001747. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001747. PMID: 12137632 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of donepezil, galantamine and rivastigmine in 938 italian patients with Alzheimer's disease: a prospective, observational study.

    Santoro A, Siviero P, Minicuci N, Bellavista E, Mishto M, Olivieri F, Marchegiani F, Chiamenti AM, Benussi L, Ghidoni R, Nacmias B, Bagnoli S, Ginestroni A, Scarpino O, Feraco E, Gianni W, Cruciani G, Paganelli R, Di Iorio A, Scognamiglio M, Grimaldi LM, Gabelli C, Sorbi S, Binetti G, Crepaldi G, Franceschi C.

    CNS Drugs. 2010 Feb 1;24(2):163-76. doi: 10.2165/11310960-000000000-00000.PMID: 20088621 [PubMed - in process]Related articles

    10.

    Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.

    Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J, Ziolkowski C.

    Curr Alzheimer Res. 2005 Jul;2(3):343-53.PMID: 15974900 [PubMed - indexed for MEDLINE]Related articles

    11.

    Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

    Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B.

    Neurology. 1998 May;50(5):1222-30.PMID: 9595967 [PubMed - indexed for MEDLINE]Related articles

    12.

    A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

    J Am Geriatr Soc. 2001 Dec;49(12):1590-9.PMID: 11843990 [PubMed - indexed for MEDLINE]Related articles

    14.

    Is functional decline necessary for a diagnosis of Alzheimer's disease?

    Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS.

    Dement Geriatr Cogn Disord. 2007;24(5):375-9. Epub 2007 Oct 3.PMID: 17914262 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.

    Fioravanti M, Flicker L.

    Cochrane Database Syst Rev. 2001;(4):CD003159. Review.PMID: 11687175 [PubMed - indexed for MEDLINE]Related articles

    16.

    Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study.

    Bellelli G, Lucchi E, Minicuci N, Rozzini L, Bianchetti A, Padovani A, Trabucchi M.

    Aging Clin Exp Res. 2005 Feb;17(1):54-61.PMID: 15847123 [PubMed - indexed for MEDLINE]Related articles

    17.

    A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.

    Suh GH, Ju YS, Yeon BK, Shah A.

    Int J Geriatr Psychiatry. 2004 Sep;19(9):817-24.PMID: 15352138 [PubMed - indexed for MEDLINE]Related articles

    18.

    Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.

    Farlow M, Potkin S, Koumaras B, Veach J, Mirski D.

    Arch Neurol. 2003 Jun;60(6):843-8.PMID: 12810489 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.

    Raskind MA, Cyrus PA, Ruzicka BB, Gulanski BI.

    J Clin Psychiatry. 1999 May;60(5):318-25.PMID: 10362441 [PubMed - indexed for MEDLINE]Related articles

    20.

    Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial.

    Aronson S, Van Baelen B, Kavanagh S, Schwalen S.

    Drugs Aging. 2009;26(3):231-9. doi: 10.2165/00002512-200926030-00004.PMID: 19358618 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk